Cargando…
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
Autores principales: | Marofi, Faroogh, Tahmasebi, Safa, Rahman, Heshu Sulaiman, Kaigorodov, Denis, Markov, Alexander, Yumashev, Alexei Valerievich, Shomali, Navid, Chartrand, Max Stanley, Pathak, Yashwant, Mohammed, Rebar N., Jarahian, Mostafa, Motavalli, Roza, Khiavi, Farhad Motavalli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349056/ https://www.ncbi.nlm.nih.gov/pubmed/34362452 http://dx.doi.org/10.1186/s13287-021-02523-2 |
Ejemplares similares
-
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021) -
CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021) -
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
por: Marofi, Faroogh, et al.
Publicado: (2021) -
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021) -
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
por: Moghadasi, Soudeh, et al.
Publicado: (2021)